Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well arsenic trioxide works in treating patients with
metastatic or unresectable cancer of the esophagus or gastroesophageal junction. Drugs used
in chemotherapy such as arsenic trioxide use different ways to stop tumor cells from dividing
so they stop growing or die